Year None2022202120202019201820172016 Date Latest Press Release September 22, 2022 Eiger BioPharmaceuticals to Present at the 2022 Ladenburg Thalmann Healthcare Conference September 6, 2022 Eiger BioPharmaceuticals Provides Update on Status of Planned Peginterferon Lambda COVID-19 Emergency Use Authorization Application September 1, 2022 Eiger BioPharmaceuticals to Participate in Three Upcoming Investor Conferences August 4, 2022 Eiger BioPharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update July 28, 2022 Eiger BioPharmaceuticals to Host Conference Call for Second Quarter 2022 Financial Results and Business Update on Thursday, August 4 July 20, 2022 Eiger Receives European Approval for Zokinvy® (lonafarnib) for Hutchinson-Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies July 18, 2022 Eiger Appoints Senior Human Resources and Organizational Executive Lisa Kelly-Croswell to Board of Directors June 27, 2022 Eiger BioPharmaceuticals Announces Results from Multiple Presentations at the European Association for the Study of the Liver (EASL) International Liver Congress™ 2022 June 13, 2022 Eiger BioPharmaceuticals Announces New Data Supporting Broader Potential of Avexitide in Patients with Post-Bariatric Hypoglycemia and Hyperinsulinemic Hypoglycemia After Gastrointestinal Surgeries June 8, 2022 Eiger BioPharmaceuticals Announces Multiple Presentations at the European Association for the Study of the Liver (EASL) International Liver Congress™ 2022 Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last »
